NCT02482051View on ClinicalTrials.gov

Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions
BacteremiaEnterobacteriaceae Infections
Trial Locations (2)

80045

University of Colorado Hospital, Aurora

80204

Denver Health Medical Center, Denver

Sponsors
All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

Accelerate Diagnostics, Inc.

INDUSTRY

lead

Denver Health and Hospital Authority

OTHER